You just read:

Charleston Laboratories, Inc. and Daiichi Sankyo, Inc. Receive Complete Response Letter from FDA for New Drug Application for CL-108 (hydrocodone, acetaminophen, promethazine) Tablets for Oral Use

News provided by

Charleston Laboratories, Inc. and Daiichi Sankyo, Inc.

03 Feb, 2017, 11:00 ET